JACLYN ALEXANDER: Open Payments
NPI 1467759035 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 23 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $351 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $82 |
| Astellas Pharma US Inc | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| MILLICENT US INC | 2 | $29 |
| Exeltis, USA Inc. | 2 | $27 |
| ABBVIE INC. | 1 | $18 |
| Hologic Sales and Service, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Veozah, XIFAXAN, MYFEMBREE, SLYND, BOTOX, APTIMA, Wegovy, GARDASIL 9.
Industry payments across KY — which companies pay providers there.
